Literature DB >> 1275056

Adrenal medullary hyperplasia. A morphometric analysis in patients with familial medullary thyroid carcinoma.

R A DeLellis, H J Wolfe, R F Gagel, Z T Feldman, H H Miller, D L Gang, S Reichlin.   

Abstract

The syndrome of familial medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid hyperplasia is inherited as an autosomal dominant trait, and is characterized by development of bilateral and multicentric thyroidal and adrenal medullary tumors. One of the earliest manifestations of adrenal medullary hyperfunction in patients with this syndrome is an increased ratio of epinephrine to norepinephrine in urine. In order to define the morphologic correlates of these early catecholamine abnormalities in a large kindred with familial MTC, a morphometric analysis based on a point-counting system to asses adrenal medullary volume was undertaken. These studies clearly revealed adrenal medullary hyperplasia as reflected by a two- to three-fold increase in medullary volume and weight as compared to age- and sex-matched controls. The increase in total medullary mass resulted from diffuse and multifocal modular proliferations of adrenal medullary cells primarily within the head and body regions of the glands. These results support the hypothesis that the pheochromocytomas in patients with familial MTC may, in fact, represent extreme degrees of nodular hyperplasia of the medulla.

Entities:  

Mesh:

Year:  1976        PMID: 1275056      PMCID: PMC2032434     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

1.  Bilateral adrenal medullary hyperplasia: a clinicopathological entity.

Authors:  J W Visser; R Axt
Journal:  J Clin Pathol       Date:  1975-04       Impact factor: 3.411

2.  Hyperplasia of the adrenal medulla in hypertension of children.

Authors:  D BIALESTOCK
Journal:  Arch Dis Child       Date:  1961-10       Impact factor: 3.791

3.  Familial endocrine tumors; report of two unrelated kindred affected with pheochromocytomas, one also with multiple thyroid carcinomas.

Authors:  P CUSHMAN
Journal:  Am J Med       Date:  1962-03       Impact factor: 4.965

4.  C-cell hyperplasia preceding medullary thyroid carcinoma.

Authors:  H J Wolfe; K E Melvin; S J Cervi-Skinner; A A Saadi; J F Juliar; C E Jackson; A H Tashjian
Journal:  N Engl J Med       Date:  1973-08-30       Impact factor: 91.245

5.  Familial medullary thyroid carcinoma, pheochromocytoma, and parathyroid adenoma (Sipple's syndrome). Study of a kindred.

Authors:  W J Catalona; K Engelman; A S Ketcham; W G Hammond
Journal:  Cancer       Date:  1971-11       Impact factor: 6.860

6.  Familial pheochromocytoma, medullary thyroid carcinoma, and parathyroid adenomas.

Authors:  E Paloyan; A Scanu; F H Straus; J R Pickleman; D Paloyan
Journal:  JAMA       Date:  1970-11-23       Impact factor: 56.272

Review 7.  The APUD cell concept and its implications in pathology.

Authors:  A G Pearse
Journal:  Pathol Annu       Date:  1974

8.  Pheochromocytoma and medullary carcinoma of thyroid.

Authors:  S N Huang; W A McLeish
Journal:  Cancer       Date:  1968-02       Impact factor: 6.860

9.  A cytophotometric study of benign and malignant phaeochromocytomas.

Authors:  P D Lewis
Journal:  Virchows Arch B Cell Pathol       Date:  1971

10.  The human adrenal gland with special reference to the vasculature.

Authors:  J W Dobbie; T Symington
Journal:  J Endocrinol       Date:  1966-04       Impact factor: 4.286

View more
  26 in total

Review 1.  The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review.

Authors:  J B Hazard
Journal:  Am J Pathol       Date:  1977-07       Impact factor: 4.307

2.  Von Hippel-Lindau's Disease, syringomyelia and multiple endocrine tumors: a complex neuroendocrinopathy.

Authors:  A Probst; M Lotz; P Heitz
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1978-06-15

Review 3.  Pheochromocytoma.

Authors:  P E Cryer
Journal:  West J Med       Date:  1992-04

4.  Multiple neuroectodermal abnormalities in pheochromocytoma patients.

Authors:  S Jansson; L E Tisell; G Hansson; G Stenström
Journal:  World J Surg       Date:  1988-10       Impact factor: 3.352

Review 5.  Diagnostic problems in pheochromocytoma.

Authors:  M Mannelli
Journal:  J Endocrinol Invest       Date:  1989-11       Impact factor: 4.256

6.  Hypertrophy of pheochromocytoma cells treated with nerve growth factor and activators of adenylate cyclase.

Authors:  A S Tischler; H Mobtaker; P W Kwan; W J Jason; R A DeLellis; H J Wolfe
Journal:  Cell Tissue Res       Date:  1987-07       Impact factor: 5.249

7.  Sporadic unilateral adrenomedullary hyperplasia with hypertension cured by adrenalectomy.

Authors:  H Dralle; S Schröder; K F Gratz; R Grote; B Padberg; R D Hesch
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

8.  Chromosome 20 deletion in human multiple endocrine neoplasia types 2A and 2B: a double-blind study.

Authors:  V R Babu; D L Van Dyke; C E Jackson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

Review 9.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

10.  Weight and shape of the human adrenal medulla in various age groups.

Authors:  E Kreiner
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.